Hydrocephalus is a common neurological disorder that leads to expansion of the cerebral ventricles and is associated with a high rate of morbidity and mortality. Most neonatal cases are of unknown etiology and are likely to have complex inheritance involving multiple genes and environmental factors. Identifying molecular mechanisms for neonatal hydrocephalus and developing noninvasive treatment modalities are high priorities. Here we use a hydrocephalic mouse model of the human ciliopathy Bardet-Biedl Syndrome (BBS) and identify a role for neural progenitors in the pathogenesis of neonatal hydrocephalus. We found that hydrocephalus in this mouse model is caused by aberrant platelet-derived growth factor receptor a (PDGFR-a) signaling, resulting in increased apoptosis and impaired proliferation of chondroitin sulfate proteoglycan 4 (also known as neuron-glial antigen 2 or NG2) + PDGFR-a + neural progenitors. Targeting this pathway with lithium treatment rescued NG2 + PDGFR-a + progenitor cell proliferation in BBS mutant mice, reducing their ventricular volume. Our findings demonstrate that neural progenitors are crucial in the pathogenesis of neonatal hydrocephalus, and we identify new therapeutic targets for this common neurological disorder.
Neonatal hydrocephalus is a common disorder affecting the human nervous system with an estimated incidence of 1-3 per 1,000 live births [1] [2] [3] [4] , creating a healthcare burden of $2 billion annually 5, 6 . Hydrocephalus leads to the expansion of cerebral ventricles and is frequently associated with morbidity and mortality [7] [8] [9] . This disease remains understudied despite being a common developmental anomaly 10 . There are multiple causes of hydrocephalus, including obstruction of cerebrospinal fluid (CSF) flow and CSF overproduction; however, a substantial portion of this disease is idiopathic in nature [9] [10] [11] [12] [13] [14] [15] [16] . Current therapies rely on invasive procedures that are associated with high failure and complication rates, making the identification of molecular mechanisms underlying neonatal hydrocephalus a high priority for the medical community 3, 9, 11, 17, 18 .
Recently, mouse models with impaired cilia function have provided insight into the mechanisms involved in hydrocephalus occurring in the absence of obstruction, a condition known as communicating hydrocephalus 10, 13, 14, 19, 20 . Mutations in genes that disrupt ependymal motile cilia structure and function hinder the beat frequency of ependymal motile cilia and CSF flow, leading to the development of hydrocephalus 13, 14, 19, 20 . Nonmotile cilia known as primary cilia extend from the surface of nearly all cell types. Primary cilia serve as sensory antennae facilitating many signaling pathways, including the Wnt 21 , sonic hedgehog (Shh) 22, 23 and PDGFR-α 24 pathways, enabling cells to respond to developmental cues at several sites of neurogenesis in the central nervous system, including the periventricular regions 25 . These nonmotile cilia are required for the normal development of neural progenitor cells (NPCs) 26, 27 .
Recent findings have demonstrated that ependymal motile cilia and CSF flow are required for the normal development of NPCs, suggesting an intimate link between the ventricular system and neural development 28 . The close proximity of NPCs to the periventricular regions suggests that these cells have a role in maintaining the integrity of the ventricular system 25, 29 . However, a role for NPCs in the pathophysiology of hydrocephalus has not been studied. In this study we investigated whether abnormal signaling through primary cilia in NPCs may contribute to the genesis of neonatal hydrocephalus. To test this hypothesis, we used a mouse model of a genetically heterogeneous autosomal recessive human disorder with impaired cilia known as BBS that is caused by mutations in 17 genes, 7 of which (BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9) form a complex known as the BBSome 30 . The cardinal features of BBS include retinal degeneration, obesity and cognitive delay 19 . Some patients with BBS have enlarged cerebral ventricles, and all BBS mouse models have communicating hydrocephalus 19, 31, 32 . Here we demonstrate that abnormal development of NPCs specifically expressing NG2 and PDGFR-α leads to the development of neonatal ventriculomegaly in BBS mice. Our findings identify a new mechanism underlying hydrocephalus and provide a therapeutic target for treatment.
RESULTS

BBS mutant mice develop neonatal hydrocephalus
We have previously shown that BBS mutant mice homozygous for the most common human BBS mutation (Bbs1 M390R/M390R mice) develop ventricular dilatation similar to that reported in human patients with BBS 19, 31, 32 (Fig. 1a,b) . Ventriculomegaly in Bbs1 M390R/M390R mice is fully penetrant and accompanied by neurological deficits, similar to in patients with hydrocephalus 3, 9, 19, 31, 32 . We use the term hydrocephalus in Bbs1 M390R/M390R mice to describe the ventriculomegaly that has been previously reported in other mouse models 4, 9, 10, [14] [15] [16] 20 .
We first examined the time of onset of hydrocephalus in Bbs1 M390R/M390R brains by examining H&E-stained sections. Dilation of the lateral ventricles began between postnatal day (P) 0 and P3 in Bbs1 M390R/M390R mice ( Fig. 1c,d) . Notably, this timing is before the maturation of ependymal motile cilia, which occurs from P5-P10 (refs. 10, 13, 14) , suggesting that the onset of hydrocephalus in Bbs1 M390R/M390R mice occurs independently of ependymal motile cilia function ( Fig. 1e) .
Aberrant apoptosis and proliferation in Bbs1 mice
We next studied whether known causes of hydrocephalus contribute to the phenotype in Bbs1 M390R/M390R mice. Injection of Evans blue dye showed no evidence of obstructive hydrocephalus ( Supplementary  Fig. 1 ). We found no evidence of excess CSF production in Bbs1 M390R/M390R mice on the basis of normal choroid plexus ultrastructure and CSF ion concentrations ( Supplementary Fig. 1 ).
We therefore sought to identify other potential mechanisms that may contribute to the early development of communicating hydrocephalus in Bbs1 M390R/M390R mice. Previous work has shown that these mice have a small corpus striatum 19 . Moreover, patients with BBS have reduced white and gray matter volume in the periventricular regions 31, 32 . Therefore, we examined apoptosis and cell proliferation in the periventricular regions in Bbs1 M390R/M390R mice to determine whether cell loss contributes to the pathophysiology of neonatal hydrocephalus. Immunofluorescent analysis using TUNEL, a marker of apoptotic cells, and BrdU, a marker of proliferating cells, identified TUNEL + cells adjacent to the lateral ventricles and BrdU + cells in the subventricular zone (SVZ) in both wild-type (WT) and Bbs1 M390R/M390R mice ( Fig. 2a) . Quantification revealed that the Bbs1 M390R/M390R mice had a twofold higher rate of apoptosis and a 50% reduction in cell proliferation in the periventricular regions at P3 and P7 relative to WT mice ( Fig. 2b) .
Abnormal development of NG2 + PDGFR-a + cells in Bbs1 mice
We next investigated the cell type that is responsible for the imbalance in apoptosis and cell proliferation by examining a number of markers of NPCs, neurons and glia. Using immunofluorescence, we double stained coronal brain slices from WT and Bbs1 M390R/M390R neonates with either TUNEL or BrdU and markers of these major cell types. We found no significant differences between WT and Bbs1 M390R/M390R brains in the number of TUNEL-labeled cells also staining positive for markers of developing (Nestin) and mature neurons (NeuN), astrocytes (glial fibrillary acidic protein (GFAP)) and oligodendrocytes [33] [34] [35] (O4; Fig. 3a and Supplementary Fig. 2) . Notably, we found that nearly all TUNEL + cells in both WT and Bbs1 M390R/M390R mice expressed NG2 and PDGFR-α, two markers of oligodendrocyte precursor cells (OLPs) [36] [37] [38] [39] [40] . Quantification revealed that a larger proportion (greater than twofold) of the TUNEL-labeled cells were also NG2 + and PDGFR-α + in Bbs1 M390R/M390R mice compared to in WT mice ( Fig. 3a) . NG2 and PDGFR-α have previously been shown to mark a particular class of OLPs that are expressed early in the lineage termed NG2 + PDGFR-α + NPCs [36] [37] [38] [39] [40] . We also examined Olig2, a Shh-induced basic helix-loop-helix transcription factor that is expressed later in the oligodendrocytic lineage than NG2 and PDGFR-α, which are both rapidly downregulated when differentiation to oligodendrocytes occurs [36] [37] [38] [39] . We found no significant overlap between TUNEL + and Olig2 + cells, indicating that in both WT and Bbs1 M390R/M390R mice, mature OLPs and oligodendrocytes are not undergoing apoptosis ( Fig. 3a) . Quantification revealed no significant difference between WT and Bbs1 M390R/M390R mice in the number of TUNEL + cells also labeled with Olig2 (P = 0.29; Fig. 3a ).
We then investigated the identity of the proliferating cells. We found that NG2 + , PDGFR-α + and Olig2 + OLPs comprised a large portion of the BrdU + cells in the SVZ of WT mice (Fig. 3b) . However, in Bbs1 M390R/M390R brains, there were approximately 50% fewer BrdU-labeled NG2 + PDGFR-α + cells in the SVZ (Fig. 3b) . WT and BBS mutant mice did not differ in the number of Olig2 + cells undergoing cell proliferation (BrdU + ) (P = 0.39; Fig. 3b ). There was also no significant difference between WT and Bbs1 M390R/M390R mice with respect to the other cell markers examined ( Fig. 3b and Supplementary Fig. 2) .
We then quantified the number of NG2 + , PDGFR-α + and Olig2 + cells within the SVZ to determine the effect of impaired survival and proliferation in these precursor cells. We found significantly (P < 0.05) fewer of these cell populations in the SVZ of Bbs1 M390R/M390R brains relative to the SVZ of WT brains (Supplementary Fig. 3 ).These results demonstrate that NG2 + PDGFR-α + NPCs have increased apoptosis and reduced proliferation, leading to reduced OLP populations in the brains of Bbs1 M390R/M390R mice.
Conditional knockout of Bbs1 leads to neonatal hydrocephalus
To confirm the involvement of NG2 + PDGFR-α + NPCs in the genesis of neonatal hydrocephalus in BBS, we generated conditional knockout Fig. 4a,b) .
These findings indicate that Bbs1 knockout in Bbs1 CKO mice is specific to a particular class of periventricular NPCs in the cortex and hypothalamus. Bbs1 CKO mice have hydrocephalus with an onset at P3 in the absence of obstruction ( Fig. 4a-d and Supplementary Fig. 4c,d) .
Moreover, neonatal hydrocephalus in Bbs1 CKO mice was 100% penetrant. TUNEL and BrdU staining revealed a twofold increase in the number of apoptotic cells (Fig. 4e,f) and a 50% reduction in the number of proliferating cells in Bbs1 CKO mice relative to in PDGFR-α Cre mice (controls) (Fig. 4g,h) . We found that nearly all TUNEL + cells and a majority of BrdU + cells in the SVZ in PDGFR-α Cre and Bbs1 CKO mice also stained positive for NG2, PDGFR-α and, to a lesser extent, Olig2 (Supplementary Fig. 5a,b) . Quantification revealed an approximately twofold increase and a 50% reduction in the number of TUNEL-and BrdU-labeled NG2 + PDGFR-α + cells, respectively, in Bbs1 CKO brains relative to control brains (Fig. 4f,h) . We found no significant differences in the number of Olig2-labeled cells undergoing apoptosis (TUNEL + , P = 0.32) or replication (BrdU + , P = 0.22; Fig. 4f,h) . These results demonstrate that the normal development of NG2 + PDGFR-α + NPCs is disrupted after Bbs1 knockout in this specific cell type. Moreover, these results confirm the involvement We then investigated whether dysfunctional motile cilia could contribute to the dilated ventricles in Bbs1 CKO brains. We examined the ultrastructure of the motile cilia in PDGFR-α Cre and Bbs1 CKO brains at P14 and 3 months of age and found no abnormalities in the ultrastructure or number of tufts of motile cilia in the lateral ventricles of the Bbs1 CKO brains (Fig. 4i) . This finding provides further evidence that hydrocephalus in BBS is caused by motile ciliaindependent processes.
Bbs1 is required for PDGFR-a signaling
We next examined cellular signaling pathways to assess the cause of the impaired survival and proliferation of NG2 + PDGFR-α + NPCs. We studied the PDGFR-α signaling pathway because it has a major role in the survival and proliferation of NG2 + PDGFR-α + NPCs [36] [37] [38] [39] [40] . We cultured primary OLPs from WT and Bbs1 M390R/M390R neonates. Treatment of WT cultures with PDGF-α, which specifically binds to PDGFR-α, resulted in a large increase in the phosphorylation of PDGFR-α and the two downstream effector proteins AKT, a master regulator of cell survival and proliferation, and glycogen synthase kinase 3 β (GSK3-β), which regulates cell proliferation [41] [42] [43] (Fig. 5a) . We showed the specificity of the response to PDGF-α in WT cultures using pretreatment with the PDGFR inhibitor AG1296, which reduced the response to PDGF-α. Bbs1 M390R/M390R -derived OLP cultures showed a blunted phosphorylation response to PDGF-α stimulation (Fig. 5a) .
To confirm these findings in vivo, we infused PDGF-α into the lateral ventricles of WT and Bbs1 M390R/M390R mice for 6 days. All infused WT mice developed atypical hyperplasias in either the medial or lateral wall of the ipsilateral ventricle, whereas none of the treated Bbs1 M390R/M390R mice showed this response (Fig. 5b,c) . Furthermore, the hyperplastic nodules in WT infused brains contained a large proportion of small, round proliferating (BrdU + ) cells (Fig. 5c,d) .
Immunostaining also identified a large increase in the population of PDGFR-α + NPCs in the medial wall of the PDGF-α-infused lateral ventricle in WT mice but not in Bbs1 M390R/M390R mice (Fig. 5d) . These findings demonstrate that Bbs1 M390R/M390R NG2 + PDGFR-α + NPCs do not respond to PDGF-α and implicate a mechanism underlying the impaired survival and proliferation of NPCs in BBS. To study the role of BBS proteins in PDGFR-α signaling, we performed immunoprecipitation experiments. In vitro and in vivo experiments revealed that PDGFR-α physically interacts with the BBSome (Supplementary  Fig. 6a,b) . These findings indicate a mechanism underlying the impaired PDGFR-α signaling in BBS.
Lithium therapy rescues hydrocephalus
We modified the neonatal hydrocephalic phenotype in Bbs1 M390R/M390R mice during the crucial perinatal period by targeting defective PDGFR-α signaling and OLP development. Lithium has been shown to enhance the proliferation and promote the survival of NPCs by stimulating phosphorylation of two downstream effectors in the PDGFR-α pathway, AKT and GSK3-β [44] [45] [46] . We treated Bbs1 M390R/+ heterozygous pregnant females, which were previously mated to heterozygous male mice, with lithium chloride or an equimolar sodium chloride solution administered in drinking water beginning at embryonic day (E) 14.5 (Fig. 6a) . Histological analysis of P14 WT and Bbs1 M390R/M390R brains revealed that lithium treatment in WT mice has no significant effect (sodium chloride compared to lithium chloride in WT mice, P = 0.17), whereas lithium treatment of Bbs1 M390R/M390R mice (n = 9) resulted in an approximately 50% reduction in the cross-sectional area of the lateral ventricles relative to sodium chloride-treated Bbs1 M390R/M390R mice (n = 5; Fig. 6a-c) . Magnetic resonance imaging (MRI) at 3 months of age revealed that the ventricular volume of the lithium-treated WT mice did not differ from that of the sodium chloride-treated WT mice (P = 0.16; Fig. 6b,c) . However, lithium-treated Bbs1 M390R/M390R mice showed an approximately 50% reduction in ventricle volume relative to controltreated Bbs1 M390R/M390R mice (Fig. 6b,c) . We found these effects of lithium in all treated Bbs1 M390R/M390R mice.
To study the mechanism underlying the effect of lithium on neonatal hydrocephalus, we examined cell proliferation and apoptosis in the npg periventricular regions of P3 mice using BrdU and TUNEL assays, respectively. Staining revealed that lithium treatment had no significant effect on the number of proliferating or apoptotic cells in WT mice (sodium chloride compared to lithium chloride in WT mice: BrdU, P = 0.29; TUNEL, P = 0.21; Fig. 6d-g) . However, lithium treatment resulted in an approximately twofold increase in the number of proliferating cells in Bbs1 M390R/M390R mice relative to sodium chloride treatment ( Fig. 6d,e) . Notably, there was no significant difference in the number of proliferating cells in sodium chloride-treated WT mice and lithium-treated Bbs1 M390R/M390R mice, indicating a complete rescue of the cell proliferation defect (P = 0.16; Fig. 6d,e ). There was also no significant difference in the number of apoptotic cells in sodium chloridetreated and lithium-treated Bbs1 M390R/M390R mice, indicating that the effect of lithium is specific to cell proliferation (P = 0.29; Fig. 6f,g) .
Furthermore, lithium treatment specifically rescued NG2 + PDGFR-α + NPC proliferation but not apoptosis in Bbs1 M390R/M390R mice (sodium chloride compared to lithium chloride in Bbs1 M394R/M394R mice: NG2 + , P = 0.36; PDGFR-α + , P = 0.38) (Fig. 6e,g and Supplementary Figs. 7  and 8 ). Lithium treatment also increased the number of proliferating Olig2 + cells in WT and Bbs1 M390R/M390R mice by more than twofold ( Fig. 6e and Supplementary Fig. 7) .
To determine the molecular mechanisms underlying the effects of lithium treatment, we examined the phosphorylation of AKT and GSK3-β. Western blot analysis revealed that lithium treatment increased the phosphorylation of GSK3-β but had no effect on the phosphorylation of AKT (Fig. 6h) . These results indicate that defective NG2 + PDGFR-α + NPC development leads to neonatal hydrocephalus in Bbs1 M390R/M390R mice. Targeting the defective PDGFR-α Also shown is the quantification of BrdU-labeled cells that also expressed NG2, PDGFR-α or Olig2 (e, right). Scale bar, d, 50 µm.
(f,g) Representative immunofluorescent images (f) and quantification (g, left) of TUNEL-labeled cells in mice treated with sodium chloride or lithium. Also shown is the quantification of TUNEL-labeled cells also expressing NG2, PDGFR-α or Olig2 (g, right). Scale bar, g, 100 µm. (h) Representative western blots of cortices from P3 WT and Bbs1 M390R/M390R mice treated with sodium chloride or lithium (left). pGSK3-β (Ser9), GSK3-β phosphorylated at Ser9; pAkt (Ser473), Akt phosphorylated at Ser473. Drawing depicting the proposed mechanism of the effect of lithium on cell proliferation in treated WT and Bbs1 M390R/M390R mice (right). Lithium increases the phosphorylation of GSK3-β, leading to an increase in cell proliferation. All data are the means ± s.e.m. *P < 0.05, **P < 0.005, ***P < 0.0005, NS, not significant determined by unpaired t test. All experiments used at least three mice per group and genotype. CPu, caudate putamen; LV, lateral ventricle. npg a r t i c l e s nature medicine VOLUME 18 | NUMBER 12 | DECEMBER 2012 1 8 0 3 signaling pathway in these NPCs rescues the proliferation of these cells, resulting in a partial rescue of hydrocephalus.
DISCUSSION
Hydrocephalus is a complex disorder involving multiple genetic and environmental components 3, 4, 9 . Thus, any single pathway or mechanism will not fully explain hydrocephalus in its entirety. Previous studies have implicated impaired ependymal motile cilia, CSF overproduction and cortical atrophy in the genesis of communicating hydrocephalus 4, 10, [13] [14] [15] [16] 20, 47 . Here we demonstrate that NG2 + PDGFR-α + NPCs have a key role in the pathogenesis of hydrocephalus. We found that impaired PDGFR-α signaling in Bbs1 M390R/M390R mice leads to increased apoptosis and reduced proliferation of NG2 + PDGFR-α + NPCs, resulting in hydrocephalus. We have also demonstrated that dysfunctional motile cilia are not the primary cause of neonatal hydrocephalus in BBS mouse models, as evidenced by ventricular dilation occurring before the development of motile cilia and the fact that ependymal cilia remain intact in mice lacking Bbs1 in PDGFR-α + cells. We have not excluded the possibility that motile cilia defects may contribute to the severity of the phenotype in older Bbs1 M390R/M390R mice. These findings steer the study of hydrocephalus beyond the ciliopathy field as evidenced by the common theme of abnormal cellular signaling in other models of hydrocephalus [14] [15] [16] [48] [49] [50] [51] . We found that NG2 + PDGFR-α + cells have impaired survival and proliferative capacities in BBS, whereas Olig2 + cells, a cell type existing within the same oligodendrocytic lineage, appear normal. This finding suggests that Bbs1 has an essential role in the survival and proliferation of NG2 + PDGFR-α + but not Olig2 + cells. The abnormal survival and proliferative capacities and the reduced populations of NG2 + PDGFR-α + NPCs in the periventricular regions may explain recent observations that patients with BBS and BBS mouse models have reduced white and gray matter volume in the periventricular subcortical structures 19, 31, 32 . The MRI findings in patients suggest a loss of cerebral tissue as a cause of ventriculomegaly 31, 32 . Our data indicate that the underlying cause of reduced cerebral tissue and ventricular dilation in patients with BBS is impaired survival and proliferation of NPCs rather than degeneration of mature neurons and glia.
The impaired PDGFR-α signaling in BBS led us to explore the therapeutic potential of targeting this pathway to modify the hydrocephalic phenotype early in development. We targeted two downstream effector proteins in the PDGFR-α signaling cascade, AKT and GSK3-β, using lithium, a drug that stimulates phosphorylation of these proteins [44] [45] [46] 52 . Phosphorylation of AKT and GSK3-β has been shown to increase cell survival and proliferation [41] [42] [43] . We found that lithium treatment selectively rescues NG2 + PDGFR-α + cell proliferation by stimulating the phosphorylation of GSK3-β, leading to a reduction in the size of the dilated ventricles in Bbs1 mutant mice. These results are consistent with those of previous studies demonstrating that lithium stimulates NPC proliferation by increasing the phosphorylation of GSK3-β, thereby suppressing its activity [44] [45] [46] 52 . Although lithium rescues cell proliferation, it has no statistically significant effect on the cell death of NG2 + PDGFR-α + NPCs. This finding may explain the partial rescue of the hydrocephalic phenotype. Rescue of both cell proliferation and apoptosis may result in a further reduction in ventricular size. To our knowledge, we are the first to target NPC development as a therapy to treat hydrocephalus in any model organism.
In addition, our results demonstrate that BBS proteins have a crucial role in PDGFR-α signaling and NG2 + PDGFR-α + NPC development in the central nervous system. The trafficking function of the BBSome is disrupted in BBS mutant mice 30 . As a result, signaling proteins are mislocalized, leading to an abnormal cellular response 23, 30, 53, 54 . Our findings suggest that the aberrant PDGFR-α signaling in Bbs1 M390R/M390R mice originates from the mistrafficking of PDGFR-α on the basis of our observations that PDGFR-α interacts with primary components of the BBSome and, hence, is a new cargo protein of the BBSome. However, the exact mechanism underlying the PDGFR-α signaling defects in BBS remains to be elucidated.
By targeting GSK3-β, we rescued the development of NG2 + PDGFR-α + NPCs and hydrocephalus in Bbs1 M390R/M390R mice. The strategy of targeting downstream effectors of signaling defects may be applicable to other BBS-associated phenotypes.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
